潤本股份(603193.SH):簽署投入產出監管協議
格隆匯5月6日丨潤本股份(603193.SH)公佈,由於公司本次部署的產研基地包含辦公、設計、工廠生產、員工宿舍及活動中心等職能,2024年競得的ZSCB-E3-3地塊面積相對較小,公司在規劃設計中發現難以有效規劃上述職能及公司長期發展需要。爲此,公司於2025年5月6日競得位於中新廣州知識城國際生物醫藥創新園,鳳亨一路以北,鳳亨二路以南,康聯一路以東ZSCB-E3-4地塊,用地面積約3.1585萬平方米(毗鄰ZSCB-E3-3地塊,可實現有效的統一規劃)。公司於2025年5月6日召開了第二屆董事會第八次會議,審議通過《關於簽署投入產出監管協議暨對外投資的議案》,同意公司以自有或自籌資金投資人民幣6億元建設“潤本生物技術研發生產基地項目”,本次建設內容主要包含辦公區、研發區、生活區、生產製造區、園區配套工程,用於開展個護用品、化妝品、醫療器械、醫藥製造行業相關產品的研發、生產製造及其配套服務。2024年競得的ZSCB-E3-3地塊上的“潤本智能智造未來工廠項目”與本次競得的ZSCB-E3-4地塊上的“潤本生物技術研發生產基地項目”將統一規劃設計及建設,建設金額合計擬爲13億元,根據《公司章程》及相關規定,本次投資“潤本生物技術研發生產基地項目”尚需經過股東大會審批通過後方可簽署《關於ZSCB-E3-4地塊用地的投入產出監管協議》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.